Canada reports outbreak of H5N5 bird flu on backyard farm
The spread of avian influenza, commonly called bird flu, has ravaged flocks around the world, disrupting supply and fuelling higher food prices. Its spread to mammals, including dairy cows in the United States, has raised concerns among governments about a risk of human transmission.
Analysis of the H5N5 virus detected in Canada's Newfoundland and Labrador province showed that it was similar to the H5N5 one which had hit Canada in 2023, the Paris-based WOAH said in a report, opens new tab, citing Canadian authorities.
It also showed that it was related to the H5N1 (2.3.4.4b) lineage that has affected some farms in Canada and has been spreading in other parts of world, mainly in the United States and Europe.
Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. Sign up here.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
2 hours ago
- Reuters
How many Palestinians has Israel's Gaza offensive killed?
July 29 (Reuters) - Palestinian health authorities say Israel's ground and air campaign against Hamas militants in the Gaza Strip has killed more than 60,000 people, with nearly a third of the dead under the age of 18. After a two-month ceasefire earlier this year, Israel resumed an all-out air and ground campaign against Hamas in March. Palestinian health officials say more than 8,500 have been killed since then. The war began on Oct. 7, 2023 when Hamas militants stormed across the border into Israeli communities. Israel says the militants killed 1,200 people, mostly civilians, and took 251 people into captivity in Gaza. A new update released by the Palestinian Ministry of Health on Tuesday put the number of those killed in Gaza during the war at 60,034 people, ranging from a newborn baby to a 110-year-old. Of those, 18,592 or 30.8% were under 18. The official Palestinian Health Ministry death toll dwarfs those killed in previous bouts of fighting between Israelis and Palestinians in Gaza since 2005, according to data from Israeli human rights organisation B'Tselem. An international monitoring group warned on Tuesday a worst-case scenario of famine is now unfolding in Gaza and immediate action is needed to avoid widespread death. This explainer examines how the Palestinian toll is calculated, how reliable it is, the breakdown of civilians and fighters killed and what each side says. In the first months of the war, death tolls were calculated simply by counting bodies that arrived in hospitals and data included names and identity numbers for most of those killed. In May 2024, the ministry included unidentified bodies, which accounted for nearly a third of the overall toll. However, since October 2024, it has only included identified bodies. A Reuters examination in March of an earlier Gaza Health Ministry list of those killed showed that more than 1,200 families were completely wiped out, including one family of 14 people. The numbers do not necessarily reflect all victims, as the Palestinian Health Ministry estimates several thousand bodies are under rubble. Official Palestinian tallies of direct deaths in the Gaza war likely undercounted the number of casualties by around 40% in the first nine months of the war as Gaza's healthcare infrastructure unravelled, according to a peer-reviewed study published in The Lancet journal in January. The U.N. human rights office also says the Palestinian authorities' figure is probably an undercount. The deaths the U.N. has verified up to March this year show that nearly 70% were women and children. Pre-war Gaza had robust population statistics and better health information systems than in most Middle East countries, public health experts told Reuters. The U.N. often cites the ministry's death figures and the World Health Organization has voiced full confidence in them. While Hamas has run Gaza since 2007, the enclave's Health Ministry also answers to the overall Palestinian Authority ministry in Ramallah in the West Bank. Gaza's Hamas-run government has paid the salaries of all those hired in public departments since 2007, including in the Health Ministry. The Palestinian Authority pays the salaries of those hired before then. Israeli officials have said previously that the death toll figures are suspect because of Hamas' control over government in Gaza and are manipulated. The government did not immediately respond to a request for comment on the Palestinian health authorities' toll passing 60,000. The Israeli military says 454 of its soldiers were killed in combat, and 2,840 others wounded since its Gaza ground operation began on Oct. 27, 2023. The Israeli military also says it goes to great lengths to avoid civilian casualties. It says Hamas uses Gaza's civilians as human shields by operating within densely populated areas, humanitarian zones, schools and hospitals, which Hamas denies. The Palestinian Health Ministry figures do not differentiate between civilians and Hamas combatants, who do not wear formal uniform or carry separate identification. The Israeli military said in January 2025 it had killed nearly 20,000 Hamas fighters. It has not provided an update since. Such estimates are reached through a combination of counting bodies on the battlefield, intercepts of Hamas communications and intelligence assessments of personnel in targets that were destroyed. Hamas has said Israeli estimates of its losses are exaggerated, without saying how many of its fighters have been killed.
Reuters
2 hours ago
- Reuters
Merck extends pause on China Gardasil shipments to year end, shares slip
July 29 (Reuters) - Merck (MRK.N), opens new tab said on Tuesday it was extending its pause on Gardasil shipments to China until at least the end of 2025 due to persistent weakness in demand for the blockbuster human papillomavirus vaccine, sending its shares down as much as 8%. The drugmaker, which reported lower second-quarter results, had previously said the pause would last at least until the middle of this year. It had suspended the shipments in February. Gardasil has been one of Merck's top growth drivers aside from blockbuster cancer immunotherapy Keytruda, and much of its international growth has come from China. Softer Gardasil demand in Japan also hurt Merck's sales, and the region is expected to be a "more significant headwind" in the back half of the year. "The Gardasil pain looks like it might drift into 2026 - credibility for management on this topic is still a sore point," said Bernstein analyst Courtney Breen. Merck CFO Caroline Litchfield tried to reassure investors and said that "Gardasil China represents a fraction of our company now, much less than 1%, we're not counting on it for growth." The company on Tuesday also announced job and cost cuts that it said will save $3 billion annually by the end of 2027, and kept its outlook for tariff-related costs unchanged at $200 million, pending any additional potential government actions. The cost cuts include $1.7 billion in annual savings from the elimination of certain administrative, sales and R&D positions, Merck said. It also plans to reduce its global real estate footprint and optimize its manufacturing network. "We are looking to reallocate money and resources from the slower growth areas of the business to fully fund fast-growing areas of our business," CEO Rob Davis said on the second-quarter earnings call. The company is focusing on newer drugs, including lung disease treatments Winrevair and Ohtuvayre, which was recently acquired in a $10 billion takeover of UK-based Verona Pharma. Investors have, however, been concerned about how Merck would replace revenue from Keytruda, the world's best-selling drug, which is set to lose patent protection toward the end of the decade. Declining sales of Gadrasil have added to Merck's pain. Shares of the company have lost more than 36% of their value since Merck first flagged weakness in China sales of the vaccine last year. Second-quarter sales of Gadrasil missed Wall Street's lowered estimates, according to data compiled by LSEG. Merck sold $1.1 billion of the vaccine, down 55% from a year ago. The acquisition of Verona "was a good first step, but investors want to see further evidence, either through additional M&A or pipeline successes, that Merck can offset the coming decline in Keytruda sales," said James Harlow, senior vice president at Novare Capital Management. Merck earned $5.4 billion, or $2.13 a share, in the second quarter, down 7% from a year earlier. Analysts had forecast earnings of $2.01. Revenue in the quarter fell 2% to $15.8 billion, compared with analysts' estimate of $15.9 billion. The company now expects to earn $8.87 to $8.97 a share in 2025, above analysts' estimates of $8.87.
Reuters
3 hours ago
- Reuters
FDA recommends 7-OH compound found in vapes be controlled
WASHINGTON, July 29 (Reuters) - The U.S. Food and Drug administration is recommending the scheduling of the 7-OH compound as a controlled substance because of its opioid properties, FDA Commissioner Marty Makary said on Tuesday. Many products containing 7-OH are available in vape stores and the compound is present in drinks and children's gummies, he said at a news conference. The FDA letter to the Drug Enforcement Administration will recommend scheduling 7-OH above a concentration threshold as a Class 1 controlled substance. The substance 7-OH is increasingly recognized as having potential for abuse because of its ability to bind to opioid receptors, the FDA said. "Yet it is sold in vape stores, in smoke shops, and convenience stores, and gas stations, that are popping up all over the United States," Makary said. The FDA is issuing a report explaining the risks of the synthetic substance, made from the kratom plant, and sending a letter to every physician in the United States warning them about the substance. "We're going to continue to try to educate the public," Makary said.
